调节器
细胞生长
酶
脆弱性(计算)
化学
生物化学
细胞生物学
MCF-7型
癌细胞
生物
酰基转移酶
细胞凋亡
线粒体
癌症
负调节器
硫酯酶
过渡(遗传学)
乳腺癌
清脆的
细胞
酰化
蛋白质-蛋白质相互作用
亚细胞定位
生长抑制
乳腺
癌症研究
程序性细胞死亡
内生
作者
Michael Salsaa,Mahtab Tavasoli,Haggag S Zein,Shubhashree Pani,Rahul S. Kathayat,Bryan C. Dickinson,Gregory D. Fairn
标识
DOI:10.1139/bcb-2025-0446
摘要
Protein S-acylation is a lipid-based, often reversible post-translational modification that can regulate many aspects of protein behavior, including subcellular localization, protein-interactions, and activity. Emerging evidence has identified roles for individual protein acyltransferases encoded by the ZDHHC in cancers, yet the roles of de- S-acylation enzymes are less clear. Recent evidence suggests that acyl-protein thioesterase (APT1)/ LYPLA1 can impact epithelial–mesenchymal transition and metastasis. This study integrates patient datasets, CRISPR dependency data, and in vitro assays to find APT1 as a context-dependent vulnerability in triple-negative breast cancer (TNBC). Despite the highest protein abundance in luminal A MCF7 cells, basal-like MDA-MB-468 cells exhibited the most prominent specific APT1 activity, reflecting subtype-specific regulation. Inhibition of APT1 with ML348 increased S-acylation of nuclear and mitochondrial proteins without altering global acylation. Functionally, APT1 inhibition reduced cell proliferation while inducing minimal apoptosis, consistent with cytostatic growth arrest. Cell-cycle analysis revealed G1 accumulation and reduced S/G2 transition, linking proteomic changes to impaired replication. These findings establish APT1 as a regulator of TNBC proliferation through dynamic de- S-acylation of cell-cycle and mitochondrial proteins, highlighting it as a potential therapeutic vulnerability in aggressive breast cancers.
科研通智能强力驱动
Strongly Powered by AbleSci AI